EZH2 is also capable of methylating a number of non-histone protein substrates, such as STAT3, which promotes PD-L1 expression in tumor cells. In addition, EZH2 has a PRC2-independent role in ...
We have also developed an epigenetic RPPA platform for histone marks and chromatin modifying proteins. For updated antibody lists by RPPA, check the Antibodies List. Pathways of the 260 antibodies: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback